Saturday , July 4 2020
Home / Audit and Guideline (page 3)

Audit and Guideline

USFDA Warning Letter for Huaian Zongheng Bio-Tech Co., Ltd

Huaian Zongheng Bio-Tech Co., Ltd MARCS-CMS 590789 — January 09, 2020 For Warning Letter Click Here –   Matters described in FDA warning letters may have been subject to subsequent interaction between FDA and the letter recipient that may have changed the regulatory status of issues discussed in the letter. For more …

Read More »

USFDA Warning Letter for Health Pharma USA LLC

Health Pharma USA LLC MARCS-CMS 588155 — December 18, 2019 For Warning Letter Click Here –   Matters described in FDA warning letters may have been subject to subsequent interaction between FDA and the letter recipient that may have changed the regulatory status of issues discussed in the letter. For more USFDA …

Read More »

USFDA Warning Letter for Cosmelab Co Ltd

Cosmelab Co Ltd MARCS-CMS 590480 — January 09, 2020 For Warning Letter Click Here –   Matters described in FDA warning letters may have been subject to subsequent interaction between FDA and the letter recipient that may have changed the regulatory status of issues discussed in the letter. For more USFDA warning …

Read More »

USFDA Warning Letter for Zhuhai Aofute Medical Technology Co., Ltd

Zhuhai Aofute Medical Technology Co., Ltd. MARCS-CMS 590945 — January 09, 2020 For Warning Letter Click Here –   Matters described in FDA warning letters may have been subject to subsequent interaction between FDA and the letter recipient that may have changed the regulatory status of issues discussed in the letter. For …

Read More »

USFDA Warning Letter for CGA Limited

CGA Limited MARCS-CMS 589028 — December 19, 2019 For Warning Letter Click Here –   Matters described in FDA warning letters may have been subject to subsequent interaction between FDA and the letter recipient that may have changed the regulatory status of issues discussed in the letter. For more USFDA warning Letter …

Read More »

USFDA Warning Letter for Tismor Health and Wellness Pty Limited

Tismor Health and Wellness Pty Limited MARCS-CMS 588104 — December 05, 2019 For Warning Letter Click Here –   Matters described in FDA warning letters may have been subject to subsequent interaction between FDA and the letter recipient that may have changed the regulatory status of issues discussed in the letter. For …

Read More »

USFDA Warning Letter for Sunstar Guangzhou Ltd

Sunstar Guangzhou Ltd. MARCS-CMS 592906 — January 22, 2020 For Warning Letter Click Here –   Matters described in FDA warning letters may have been subject to subsequent interaction between FDA and the letter recipient that may have changed the regulatory status of issues discussed in the letter. For more USFDA warning …

Read More »

USFDA Warning Letter for Dental-Kosmetik GmbH & Co. KG

Dental-Kosmetik GmbH & Co. KG MARCS-CMS 591351 — January 16, 2020 For Warning Letter Click Here –   Matters described in FDA warning letters may have been subject to subsequent interaction between FDA and the letter recipient that may have changed the regulatory status of issues discussed in the letter. For more …

Read More »

USFDA Warning Letter for Baja Fur S.A. de C.V.

Baja Fur S.A. de C.V. MARCS-CMS 590791 — December 13, 2019 For Warning Letter Click Here –   Matters described in FDA warning letters may have been subject to subsequent interaction between FDA and the letter recipient that may have changed the regulatory status of issues discussed in the letter. For more …

Read More »

USFDA Warning Letter for Essnd Global

Essnd Global MARCS-CMS 595850 — February 14, 2020 For Warning Letter Click Here –   Matters described in FDA warning letters may have been subject to subsequent interaction between FDA and the letter recipient that may have changed the regulatory status of issues discussed in the letter. For more USFDA warning Letter …

Read More »